{"contacts": [{"terms": [{"accession": "MS:1002037", "name": "dataset submitter"}, {"accession": "MS:1000586", "name": "contact name", "value": "Karl Clauser"}, {"accession": "MS:1000589", "name": "contact email", "value": "clauser@broadinstitute.org"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Broad Institute of MIT and Harvard"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Steven A. Carr"}, {"accession": "MS:1000589", "name": "contact email", "value": "scarr@broadinstitute.org"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Broad Institute of MIT and Harvard"}]}], "description": "Klaeger S, Apffel A, Clauser KR, Sarkizova S, Oliveira G, Rachimi S, Le PM, Tarren A, Chea V, Abelin JG, Braun DA, Ott PA, Keshishian H, Hacohen N, Keskin DB, Wu CJ, Carr SA. 2021. Mass spectrometry is the most effective method to directly identify peptides presented on HLA molecules. However, current standard approaches often use 500 million or more cells as input  to achieve high coverage of the immunopeptidome and therefore these methods are not compatible with the often limited amounts of tissue available from clinical tumor samples. Here, we evaluated microscaled basic reversed-phase fractionation to separate HLA peptide samples off-line followed by ion mobility coupled to LC-MS/MS for analysis. The combination of these two separation methods enabled identification of 20% to 50% more peptides compared to samples analyzed without either prior fractionation or use of ion mobility alone. We demonstrate coverage of HLA immunopeptidomes with up to 8,107 distinct peptides starting with as few as 100 million cells. The increased sensitivity obtained using our methods can provide data useful to improve HLA binding prediction algorithms as well as to enable detection of clinically relevant epitopes such as neoantigens.", "fullDatasetLinks": [{"accession": "MS:1002488", "name": "MassIVE dataset URI", "value": "http://massive.ucsd.edu/ProteoSAFe/dataset.jsp?task=a1638beae5d04267a99f92c550c60b34"}, {"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://massive.ucsd.edu/MSV000087743/"}], "identifiers": [{"accession": "MS:1002487", "name": "MassIVE dataset identifier", "value": "MSV000087743"}, {"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD027048"}, {"accession": "MS:1001921", "name": "ProteomeXchange accession number version number", "value": "1"}], "instruments": [{"accession": "MS:1003028", "name": "Orbitrap Exploris 480"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "HLA class I"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "Immunopeptidomics"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "FAIMS"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "Ion mobility"}], "modifications": [{"accession": "MS:1001460", "name": "unknown modification"}, {"accession": "MS:1001460", "name": "unknown modification"}, {"accession": "MS:1001460", "name": "unknown modification"}, {"accession": "MS:1001460", "name": "unknown modification"}], "publications": [{"terms": [{"accession": "MS:1002853", "name": "Dataset with no associated published manuscript"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens"}, {"accession": "MS:1001468", "name": "taxonomy: common name", "value": "human"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Optimized liquid and gas phase fractionation increases HLA-peptidome coverage for primary cell and tissue samples"}